Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,322 | -8,352 | -4,925 | -15,666 | -21,075 |
| Depreciation Amortization | 3 | 144 | 186 | 349 | 685 |
| Accounts receivable | -59 | 273 | 19 | -302 | 27 |
| Other Working Capital | 2,389 | 208 | -337 | -2,154 | 1,511 |
| Other Operating Activity | 3,221 | 471 | -2,635 | 4,357 | 3,235 |
| Operating Cash Flow | $-4,768 | $-7,256 | $-7,692 | $-13,416 | $-15,616 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 5,000 | 0 | 2,518 |
| PPE Investments | -6 | N/A | -2 | -11 | -98 |
| Other Investing Activity | 0 | 0 | 0 | -83 | -63 |
| Investing Cash Flow | $-6 | $N/A | $4,998 | $-94 | $2,356 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 450 | 414 | 350 | 347 | 314 |
| Debt Issued | 379 | N/A | N/A | N/A | N/A |
| Debt Repayment | -27 | N/A | N/A | -3,766 | -4,570 |
| Common Stock Issued | 1,175 | 6,553 | 1,828 | 8,736 | 28,119 |
| Other Financing Activity | -87 | -378 | -363 | -327 | -124 |
| Financing Cash Flow | $1,890 | $6,590 | $1,814 | $4,991 | $23,739 |
| Exchange Rate Effect | N/A | -6 | -8 | -1 | -1 |
| Beginning Cash Position | 3,623 | 5,787 | 6,675 | 15,195 | 4,717 |
| End Cash Position | 739 | 5,115 | 5,787 | 6,675 | 15,195 |
| Net Cash Flow | $-2,884 | $-672 | $-888 | $-8,520 | $10,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,768 | -7,256 | -7,692 | -13,416 | -15,616 |
| Capital Expenditure | -6 | N/A | -2 | -11 | -98 |
| Free Cash Flow | -4,774 | -7,256 | -7,694 | -13,428 | -15,714 |